company background image
2422 logo

Sichuan Kelun Pharmaceutical SZSE:002422 Stock Report

Last Price

CN¥29.93

Market Cap

CN¥47.6b

7D

-1.1%

1Y

-0.2%

Updated

22 Apr, 2024

Data

Company Financials +

Sichuan Kelun Pharmaceutical Co., Ltd.

SZSE:002422 Stock Report

Market Cap: CN¥47.6b

Sichuan Kelun Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sichuan Kelun Pharmaceutical
Historical stock prices
Current Share PriceCN¥29.93
52 Week HighCN¥33.28
52 Week LowCN¥21.60
Beta0.043
1 Month Change-0.96%
3 Month Change22.41%
1 Year Change-0.23%
3 Year Change45.29%
5 Year Change4.65%
Change since IPO100.33%

Recent News & Updates

If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Mar 19
If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

Mar 04
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Feb 27
These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Recent updates

If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Mar 19
If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

Mar 04
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Feb 27
These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Shareholder Returns

2422CN PharmaceuticalsCN Market
7D-1.1%-1.1%-0.4%
1Y-0.2%-15.9%-16.2%

Return vs Industry: 002422 exceeded the CN Pharmaceuticals industry which returned -15.9% over the past year.

Return vs Market: 002422 exceeded the CN Market which returned -16.2% over the past year.

Price Volatility

Is 2422's price volatile compared to industry and market?
2422 volatility
2422 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement7.9%
Market Average Movement8.9%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 002422 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002422's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199620,000Sichuan Liuwww.kelun.com

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China.

Sichuan Kelun Pharmaceutical Co., Ltd. Fundamentals Summary

How do Sichuan Kelun Pharmaceutical's earnings and revenue compare to its market cap?
2422 fundamental statistics
Market capCN¥47.61b
Earnings (TTM)CN¥2.46b
Revenue (TTM)CN¥21.45b

19.4x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2422 income statement (TTM)
RevenueCN¥21.45b
Cost of RevenueCN¥0
Gross ProfitCN¥21.45b
Other ExpensesCN¥19.00b
EarningsCN¥2.46b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)1.54
Gross Margin100.00%
Net Profit Margin11.45%
Debt/Equity Ratio35.2%

How did 2422 perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

39%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.